Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
2006 · British Journal of Cancer · 200 citations
https://doi.org/10.1038/sj.bjc.6602922
J
J. M. S. Bartlett
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
1.6K
Citations
16
h-index
26
i10-index
J. M. S. Bartlett is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies. The author has an h-index of 16, co-authored 46 publications.
Papers by this author
works<i>Best Practice No 176</i>
2004 · Journal of Clinical Pathology · 179 citations
https://doi.org/10.1136/jcp.2003.007724
HER2 testing in the UK: further update to recommendations
2008 · Journal of Clinical Pathology · 136 citations
https://doi.org/10.1136/jcp.2007.054866
HER2 testing in the UK: recommendations for breast and gastric in-situ hybridisation methods
2011 · Journal of Clinical Pathology · 77 citations
https://doi.org/10.1136/jcp.2011.089847
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · The Lancet Diabetes & Endocrinology · 36 citations
https://doi.org/10.1016/s2213-8587(23)00253-x
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · The Lancet Child & Adolescent Health · 33 citations
https://doi.org/10.1016/s2352-4642(23)00316-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat